Drug reduces risk of relapse with neuromyelitis optica

The drug eculizumab, a synthetic antibody that inhibits the inflammatory response, significantly reduced the risk of relapse with neuromyelitis optica spectrum disorder (NMOSD). This rare but severe autoimmune inflammatory disorder can cause blindness, paralysis and

Repeat heart attack and early death linked to hospitals with low care scores: The study found that risk was lower in patients who were admitted to teaching hospitals

Heart attack patients treated at hospitals with low care scores are at greater risk for another heart attack and/or death due to cardiovascular causes, Rutgers researchers found. Their study, published in the American Journal of

Inactive ingredients in pills and capsules may cause allergic, adverse reactions: Majority of oral medications available to consumers contain ingredients that can affect sensitive individuals

A new study led by a team of investigators from Brigham and Women’s Hospital and Massachusetts Institute of Technology has found that the vast majority of the most frequently prescribed medications in the U.S. contain